Medifast (NYSE: MED) reported Q4 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $62.5 million versus the consensus estimate of $65.01 million.

For earnings history and earnings-related data on Medifast (MED) click here.